MedPath

On Versus Off Pump Myocardial Revascularization Study

Phase 4
Completed
Conditions
Coronary Artery Disease
Registration Number
NCT01290952
Lead Sponsor
Medtronic Italia
Brief Summary

Compare completeness and modality of revascularization, operative and postoperative results and 1 year clinical outcomes in unselected high risk patients referred for primary coronary artery bypass surgery. Patients will be randomized to undergo off-pump coronary artery bypass graft (OPCAB) or coronary artery bypass graft with cardiopulmonary bypass (CPB/CAB).

Detailed Description

The initial application of off-pump coronary artery bypass in the early nineties was mainly directed to highly selected and relatively low risk surgical patients. Since then there has been a growing body of evidence suggesting many potential advantages of the OPCAB technique over the conventional cardiopulmonary bypass (CPB) technique in different groups of high-risk patients.

On-off study is a multicentre, prospective, randomized, parallel, trial.Patients indicated for elective or urgent isolated coronary artery bypass graft with additive European System for Cardiac Operative Risk Evaluation ≥ 6 were enrolled. Patients in cardiogenic shock were excluded. Patients were randomly assigned either to coronary artery bypass surgery with cardiopulmonary bypass (ON arm) or to off-pump coronary artery bypass graft (OFF arm). The composite primary end point included operative mortality, myocardial infarction, stroke, renal failure, re-operation for bleeding and adult respiratory distress syndrome, within 30 days after surgery. The total planned sample size was 693 patients; the actual number of enrolled patients was 411,according to the results of the interim analysis scheduled at 400 enrollments (alfa-spending=0.029, Pocock method).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
411
Inclusion Criteria
  • Pts candidate to a myocardial revascularization for any patter of coronary artery disease, ventricular dysfunction or any other co-morbidity
  • EUROSCORE ≥ 6
  • Pts who signed the Informed Consent
  • Age ≥ 18 years
Exclusion Criteria
  • Patients in cardiogenic shock requiring emergency surgery or preoperative intra-aortic balloon pump
  • Patients requiring additional surgical procedures
  • Porcelain Aorta
  • Lack of informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Patients With Post-operative Combined Endpoint (i.e. With One or More of the Following)30 days

Number of patients with one or more of the following:

* Operative Mortality

* Myocardial Infarction

* Postoperative neurological complications

* Renal failure

* ARDS (Acute Respiratory Distress Syndrome)

* Bleeding

Secondary Outcome Measures
NameTimeMethod
Number of Patients With Secondary Combined Endpoint (i.e. With One or More of the Following)30 days

Number of patients with one of more of the following:

* Post-operative Atrial Fibrillation

* IAPB (Intra-Aortic Balloon Pump) insertion and low cardiac output syndrome

* Ventilation \> 24h

* Sternal wound infection or dehiscence

Trial Locations

Locations (8)

Policlinico

🇮🇹

Bari, Italy

S. Anna e S. Sebastiano

🇮🇹

Caserta, Italy

Ospedale Luigi Sacco

🇮🇹

Milano, Italy

European Hospital

🇮🇹

Roma, Italy

Ospedale S. Camillo

🇮🇹

Roma, Italy

Ospedale S. Giovanni di Dio e Ruggi d'Aragona

🇮🇹

Salerno, Italy

Ospedale Molinette

🇮🇹

Torino, Italy

University Hospital

🇨🇭

Zurich, Switzerland

Policlinico
🇮🇹Bari, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.